 |
|
A multicenter cross-sectional study on the prevalence of overactive bladder and its impacts on the quality of life in gynecologic outpatients
Do Young Kim, Da Hae Jang, Hyun Jin Kim, Sa Ra Lee, Myung Jae Jeon, Jung-Ho Shin, Hee Dong Chae
Obstet Gynecol Sci. 2020;63(2):181-186. Published online 2020 Feb 20 DOI: https://doi.org/10.5468/ogs.2020.63.2.181
|
|
Citations to this article as recorded by
 A Double-blind, Randomised Four-way Crossover Study to Compare the Effects of Fesoterodine 4 and 8 mg Once Daily and Qxybutynin 5 mg Twice Daily After Steady-state Dosing Versus Placebo on Cognitive Function in Overactive Bladder–wet Patients over the Age
Saima Rajabali, Prosper Asaana, Sahar Nazari, Adrian Wagg
European Urology Focus.2024;[Epub] CrossRef The relationship between overactive bladder, metabolic syndrome and shift work: A literature review
Debora Rosa, Giulia Villa, Loris Bonetti, Serena Togni, Anne Destrebecq, Emanuele Montanari, Stefano Terzoni
International Journal of Urological Nursing.2022; 16(2): 73. CrossRef Prevalence of pelvic floor dysfunction: a Saudi national survey
Ahmed Al-Badr, Zarqa Saleem, Ouhoud Kaddour, Bader Almosaieed, Ashraf Dawood, Mohamad Al-Tannir, Faisal AlTurki, Reem Alharbi, Nasser Alsanea
BMC Women's Health.2022;[Epub] CrossRef Treatment of Overactive Bladder in the Frail Patient
Sage Vincent, Anthony Tokarski, Alana Murphy
Current Bladder Dysfunction Reports.2020; 15(4): 386. CrossRef
|